Compare Abbott Laboratories (ABT) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Abbott Laboratories trades at $95.62 (market cap $166.94B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.65. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and iShares iBoxx $ High Yield Corporate Bond ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | HYG | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Fixed Income |
52-Week High | $136.62 | $81.32 |
52-Week Low | $82.57 | $78.72 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
HYG trades at $79.87, up 0.2% today, with a neutral technical signal. The ETF shows consistent dividend distributions, including $0.42 in May 2026. Bond ETF inflows are surging 60% year-over-year as investors seek yield amid market volatility and Fed uncertainty, according to CNBC on June 25, 2026. Technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains cautious due to interest rate sensitivity and inflation concerns. Risks include potential Fed rate hikes and narrowing market breadth. The high-yield sector faces pressure from bearish bets, but demand for yield provides support. Investors should weigh income stability against macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
